Cancer Prevention Pharmaceuticals, Inc.

Gilead Sciences is set to learn this week whether its breast cancer treatment, sacituzumab govitecan, is on track to receive EU-wide marketing approval. The drug is authorized as Trodelvy in five oth

The European Medicines Agency has recommended for EU-wide approval nine new drugs, including three orphan medicines – BeiGene ’s Brukinsa (zanubrutinib) for treating Waldenström’s macroglobulinemia,

The European Medicines Agency has recommended pan-EU marketing authorization for Nexviadyme (avalglucosidase alfa), Sanofi Genzyme ’s enzyme replacement therapy for the rare, degenerative muscle diso

Japanese pharma company Kyowa Kirin is set to find out this week whether istradefylline, its add-on drug for treating “off” episodes in adults with Parkinson’s disease, will be on track to receive E